{"id":"W2127685474","doi":"10.1200/jco.2007.15.2280","title":"Erlotinib for Advanced Non–Small-Cell Lung Cancer in the Elderly: An Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21","year":2008,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":222,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Queen's University; University Health Network","funders":"American Society of Clinical Oncology; AstraZeneca","keywords":"Medicine; Erlotinib; Lung cancer; Internal medicine; Placebo; Hazard ratio; Cancer; Clinical trial; Chemotherapy; Quality of life (healthcare); Surgery; Gastroenterology; Epidermal growth factor receptor; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008849779,0.0001405648,0.002302852,0.0001548112,0.00009366184,0.00000357273,0.0003372616,0.0001835728,0.00007382779],"category_scores_gemma":[0.00467858,0.00007140006,0.000896175,0.0005653045,0.0002096372,0.0001005055,0.00002798194,0.000562319,5.711139e-8],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004397739,"about_ca_system_score_gemma":0.01551723,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.03208002,"about_ca_topic_score_gemma":0.5316696,"domain_scores_codex":[0.9933649,0.001262825,0.004306651,0.0002246397,0.0006468765,0.0001941009],"domain_scores_gemma":[0.9894953,0.005401402,0.003684871,0.0002261978,0.001025166,0.0001670906],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003642511,0.006827572,0.9471015,0.00004016283,0.005937391,0.00005569666,0.001119417,0.007309487,0.00006371794,0.00004314086,0.003034171,0.02482524],"study_design_scores_gemma":[0.01953246,0.006941829,0.9536471,0.00007215027,0.009021735,0.000011277,0.0009083639,0.001147951,0.00001970044,0.00002742875,0.008593212,0.00007682321],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9909394,0.0005188325,0.0001143184,0.004548507,0.002043939,0.001348279,0.0001184968,0.000001564183,0.0003666202],"genre_scores_gemma":[0.9958321,0.00066548,0.0007100865,0.001650093,0.0007987455,0.0001044537,0.000007155207,0.00001055322,0.0002213299],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4995896,"threshold_uncertainty_score":0.9900639,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.22132737951902,"score_gpt":0.5780171170297974,"score_spread":0.3566897375107774,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}